Skip to main content
Livermore
Livermore
ZHEN

Baxter Bros Inc

SEC CIK
0001096783
Latest filing
Aug 6, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Baxter Bros Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,441
Value
$715.8K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Baxter Bros Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,441$715.8K0.1%+8+0.6%AddedHolders
Q1 20261,433$639.9K0.1%−31−2.1%ReducedHolders
Q4 20251,464$663.7K0.1%−85−5.5%ReducedHolders
Q3 20251,549$606.6K0.1%+108+7.5%AddedHolders
Q2 20251,441$641.5K0.1%+213+17.3%AddedHolders
Q1 20251,228$595.4K0.1%+206+20.2%AddedHolders
Q4 20241,022$411.6K0.1%−10−1.0%ReducedHolders
Q3 20241,032$480.0K0.1%+52+5.3%AddedHolders
Q2 2024980$463.1K0.1%−46−4.5%ReducedHolders
Q1 20241,026$428.9K0.1%+130+14.5%AddedHolders
Q4 2023896$364.6K0.1%+76+9.3%AddedHolders
Q3 2023820$285.1K<0.1%00.0%UnchangedHolders
Q2 2023820$288.6K<0.1%00.0%UnchangedHolders
Q1 2023820$258.4K<0.1%−68−7.7%ReducedHolders
Q4 2022888$256.0K<0.1%−1−0.1%ReducedHolders
Q3 2022889$257.0K<0.1%−375−29.7%ReducedHolders
Q2 20221,264$356.0K0.1%−175−12.2%ReducedHolders
Q1 20221,439$376.0K0.1%−150−9.4%ReducedHolders
Q4 20211,589$349.0K0.1%−300−15.9%ReducedHolders
Q3 20211,889$343.0K0.1%−1,315−41.0%ReducedHolders
Q2 20213,204$646.0K0.1%−214−6.3%ReducedHolders
Q1 20213,418$734.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.